BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
The U.S. Patent and Trademark Office Grants BIOMARK PATENT THAT EXPANDS ITS CLAIMS COVERING ITS
BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research At 2024 GPEN Conference Vancouver, British Columbia
Form 7 Monthly Progress Report May 2024 Name of Listed Issuer: Trading Symbol: Number of
Today is a day to honour Dr Daniel Sitar: Fellowship Canadian Society of Pharmacology and
Form 7 Monthly Progress Report May 2024 Name of Listed Issuer: Trading Symbol: Number of
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2